What this video covers
A video from AFAR, posted on Jan 21, 2026. It is about the science of aging.
It comes from a research institute, foundation or scientific meeting on aging. We link to it; we don't make or endorse it. Research stages on this site come from published studies, not from videos.
From the video's description
The State of Gerotherapeutics: Next Gen Interventions to Extend Healthy Living | AFAR Webinar (September 22, 2025) Leaders from the academic, clinical, and private sectors clarified how both repurposing existing drugs and developing novel compounds can extend healthspan; unpacked the need for human trials, the importance of an FDA indication for aging, as well as the risks in off-label use and harm of radical life extension claims; counter myths and misinformation with accurate expectations; explored how drug and lifestyle interventions work together to extend healthspan; and more. In this webinar, New York Times health reporter Dana G. Smith, PhD, moderated a discussion on the current state of existing and emerging drug interventions to extend healthspan with Nir Barzilai, MD (President, Academy of Health and Lifespan Research); Rafael de Cabo, PhD (Chief, Translational Gerontology Br…
Written by AFAR on YouTube.
More videos like this
Research instituteKejun (Albert) Ying at ARDD2026: An open world model for human health and mortalityThe science of aging
Research instituteHao Pei at ARDD2026: Aging Is Multidimensional — So Must Be the DataThe science of aging
Research instituteYuancheng (Ryan) Lu at ARDD2026: Functional Genomics and Virtual ScreeningThe science of aging
Research instituteCapital Markets and Philanthropy Panel at ARDD2026: What does AI in Longevity Biotech really need?The science of aging